Mersana Therapeutics, Inc. (MRSN)
29.10
+0.10
(+0.34%)
USD |
NASDAQ |
Dec 24, 11:08
Mersana Therapeutics SG&A Expense (TTM): 31.53M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cidara Therapeutics, Inc. | 28.09M |
| Day One Biopharmaceuticals, Inc. | 116.18M |
| Semler Scientific, Inc. | 34.10M |
| Cue Biopharma, Inc. | 16.81M |
| Scholar Rock Holding Corp. | 150.18M |